This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimerâs disease. Nat Genet. 2011;43:429â35.
Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimerâs disease. Nat Genet. 2013;45:1452â8.
Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimerâs disease. Nat Genet. 2011;43:436â41.
Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, Hill WD, et al. GWAS on family history of Alzheimerâs disease. Transl Psychiatry. 2018;8:99.
Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimerâs disease risk. Nat Genet. 2019;51:404â13.
Schwartzentruber J, Cooper S, Liu JZ, Barrio-Hernandez I, Bello E, Kumasaka N, et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimerâs disease risk genes. Nat Genet. 2021;53:392â402.
de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, et al. Common variants in Alzheimerâs disease and risk stratification by polygenic risk scores. Nat Commun. 2021;12:3417.
Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimerâs disease. Nat Genet. 2021;53:1276â82.
Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimerâs disease and related dementias. Nat Genet. 2022;54:412â36.
Cuyvers E, Sleegers K. Genetic variations underlying Alzheimerâs disease: evidence from genome-wide association studies and beyond. Lancet Neurol. 2016;15:857â68.
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimerâs disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51:414â30.
Liu JZ, Erlich Y, Pickrell JK. Case-control association mapping by proxy using family history of disease. Nat Genet. 2017;49:325â31.
Lake J, Warly Solsberg C, Kim JJ, Acosta-Uribe J, Makarious MB, Li Z, et al. Multi-ancestry meta-analysis and fine-mapping in Alzheimerâs disease. Mol Psychiatry. 2023;28:3121â32.
Evangelou E, Ioannidis JP. Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet. 2013;14:379â89.
Gao S, Wang T, Han Z, Hu Y, Zhu P, Xue Y, et al. Interpretation of 10 years of Alzheimerâs disease genetic findings in the perspective of statistical heterogeneity. Brief Bioinform. 2024;25:bbae140.
Liu G, Zhang S, Cai Z, Ma G, Zhang L, Jiang Y, et al. PICALM Gene rs3851179 Polymorphism Contributes to Alzheimerâs Disease in an Asian Population. Neuromolecular Med. 2013;15:384â8.
Rucker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8:79.
Magi R, Horikoshi M, Sofer T, Mahajan A, Kitajima H, Franceschini N, et al. Trans-ethnic meta-regression of genome-wide association studies accounting for ancestry increases power for discovery and improves fine-mapping resolution. Hum Mol Genet. 2017;26:3639â50.
Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016;44:D877â881.
Acknowledgements
This work was supported by funding from the Beijing Natural Science Foundation (Grant No. JQ21022), National Natural Science Foundation of China (Grant No. 82071212, 81901181, and 12026414), and Beijing Ten Thousand Talents Project (Grant No. 2020A15). This work was also partially supported by funding from the Science and Technology Beijing One Hundred Leading Talent Training Project (Z141107001514006), the Beijing Municipal Administration of Hospitalsâ Mission Plan (SML20150802), the Funds of Academic Promotion Programme of Shandong First Medical University & Shandong Academy of Medical Sciences (No. 2019QL016, No. 2019PT007).
Author information
Authors and Affiliations
Contributions
GYL designed the study; GYL, TW, ZFH and SG analyzed the data; all authors contributed to the interpretation of the results and critical revision of the manuscript for important intellectual content and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisherâs note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Gao, S., Zhu, P., Wang, T. et al. Alzheimerâs disease genome-wide association studies in the context of statistical heterogeneity. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02654-x
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41380-024-02654-x